FC
LLY icon

Fairscale Capital’s Eli Lilly LLY Stock Holding History

Fairscale Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$548K Hold
596
– – 0.38% 43
2025
Q4 		$641K Sell
596
-63
-10% -$60.2K 0.42% 38
2025
Q3 		$503K Hold
659
– – 0.35% 45
2025
Q2 		$488K Buy
659
+122
+23% +$94.8K 0.35% 46
2025
Q1 		$444K Hold
537
– – 0.4% 42
2024
Q4 		$415K Hold
537
– – 0.36% 45
2024
Q3 		$476K Sell
537
-10
-2% -$8.99K 0.42% 45
2024
Q2 		$515K Buy
+547
New +$438K 0.46% 38

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fairscale Capital's LLY Position: Q1 2026 in Review

Fairscale Capital held its Eli Lilly (LLY) position steady in Q1 2026 at 596 shares worth $548K. The position accounts for 0.38% of the portfolio, ranked #43.

Fairscale Capital first reported a position in LLY in Q2 2024 and has held it in 8 quarters since. The position peaked at $641K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fairscale Capital held 596 shares of Eli Lilly worth $548K as of Q1 2026.
  • Fairscale Capital left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.38% of Fairscale Capital's portfolio in Q1 2026, its #43 holding.
  • Fairscale Capital first reported a position in Eli Lilly in Q2 2024 and has held it in 8 quarters since.
  • Fairscale Capital's Eli Lilly position peaked at $641K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fairscale Capital's 13F filing for Q1 2026, filed 11 May 2026.